Cite
Circosta P, Elia AR, Landra I, et al. Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. Oncoimmunology. 2018;7(4):e1341032doi: 10.1080/2162402X.2017.1341032.
Circosta, P., Elia, A. R., Landra, I., Machiorlatti, R., Todaro, M., Aliberti, S., Brusa, D., Deaglio, S., Chiaretti, S., Bruna, R., Gottardi, D., Massaia, M., Giacomo, F. D., Guarini, A. R., Foà, R., Kyriakides, P. W., Bareja, R., Elemento, O., Chichili, G. R., Monteleone, E., Moore, P. A., Johnson, S., Bonvini, E., Cignetti, A., & Inghirami, G. (2018). Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. Oncoimmunology, 7(4), e1341032. https://doi.org/10.1080/2162402X.2017.1341032
Circosta, Paola, et al. "Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms." Oncoimmunology vol. 7,4 (2018): e1341032. doi: https://doi.org/10.1080/2162402X.2017.1341032
Circosta P, Elia AR, Landra I, Machiorlatti R, Todaro M, Aliberti S, Brusa D, Deaglio S, Chiaretti S, Bruna R, Gottardi D, Massaia M, Giacomo FD, Guarini AR, Foà R, Kyriakides PW, Bareja R, Elemento O, Chichili GR, Monteleone E, Moore PA, Johnson S, Bonvini E, Cignetti A, Inghirami G. Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. Oncoimmunology. 2018 Feb 08;7(4):e1341032. doi: 10.1080/2162402X.2017.1341032. eCollection 2018. PMID: 29632712; PMCID: PMC5889202.
Copy
Download .nbib